Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Condition: Recurrent Respiratory PapillomatosisInterventions: Drug: celebrex (celecoxib); Drug: placebo capsulesSponsors: North Shore Long Island Jewish Health System; National Institute on Deafness and Other Communication Disorders (NIDCD)Completed - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Audiology | Celebrex | Deafness | Papillomatosis | Research | Respiratory Medicine | Study